Alzheimer’s disease (AD) care is entering a transformative phase. Advances in disease modifying therapies, blood based biomarkers, and digital technologies are shifting the focus from late stage diagnosis to earlier identification and proactive management. While these innovations hold significant promise, their real impact will depend on how effectively they are integrated into everyday healthcare.

Experts convened at a recent IQVIA webinar to examine how the Alzheimer’s care pathway is evolving and what health systems must do to prepare for earlier intervention at scale.

A central theme was the need to move detection upstream. Alzheimer’s disease begins long before symptoms appear, sometimes decades earlier. Emerging biomarkers and risk stratification tools are creating opportunities to identify individuals earlier, when interventions would be most effective. This shift places growing importance on primary care, where dementia risk assessment could increasingly become part of routine health reviews rather than a referral driven, reactive process.

AI driven risk models and population level analytics will enable a step‑change in scalable, proactive Alzheimer’s care. By leveraging data already collected in routine care, these tools can help identify individuals at higher risk and prioritize access to formal diagnostics, supporting earlier intervention while easing pressure on specialist services.

The discussion also highlighted the urgent need to rethink how outcomes are measured. Traditional cognitive assessments are often burdensome and insufficiently sensitive to early disease. More patient centered approaches, combining digital assessments, real world data, and patient reported outcomes, are needed to capture how people feel, function, and live across the disease continuum.

Finally, panelists emphasized that innovation alone is not enough. Implementation science is essential to ensure new tools and technologies can be piloted, evaluated, and sustainably embedded into real world clinical workflows.

To explore these insights in more detail, including expert perspectives and practical implications, read the Insight Brief.